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Abstract: In this paper we analyse the use of different models to describe the effects of
propofol in the induction of hypnosis on a patient during surgery. In particular, we consider
the standard three-compartmental pharmacokinetics/pharmacodynamics Wiener model and a
suitable reduction of it. The estimation of the parameters is based on real bispectral index scale
surgical data and it is performed by using genetic algorithms. The results obtained for different
patients show that the standard model fits the data better than the reduced model, but it is
overparameterized and its structure is much more complex to be used for the control design.
Conversely, the simplification of the identification procedure obtained with the reduced model,
which has only three parameters, is paid by only a slight decrement of the performance.
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1. INTRODUCTION
In surgery it is essential to provide an adequate level of
anesthesia to the patient. The aim of general anesthesia
is to temporarily induce the consciousness suppression
(hypnosis), the pain inhibition (analgesia), and the muscle
contraction inhibition (or relaxation) with specific drugs.
In this paper we focus on the use of propofol as anesthetic
in total intravenous anesthesia (TIVA) and in particular
on the mathematical model that describes the human
body response to this drug and on the estimation of its
parameters. Propofol is typically used in the induction
and maintenance of a desired depth of hypnosis (DoH)
in surgery or in the sedation of patients during invasive
medical exams such as endoscopy (Byrne et al., 2008).
In order to measure the brain activity and therefore the
DoH, the bispectral index scale (BIS) is often employed.
This index is based on a bispectral analysis of the elec-
troencephalogram (EEG) and consists on a dimensionless
number which ranges from 0, equivalent to EEG silence,
to 100, equivalent to a fully awake state. In the standard
clinical practice the anesthesiologist manually regulates
the propofol infusion based on this index, on recommended
doses and on his/her experience. In order to improve the
efficacy of the treatment and the safety of the patient,
automatic and semi-automatic drug infusion systems have
been developed in the last decades. In particular, the
so-called target controlled infusion (TCI) (Ehrenfeld and
eds., 2014) has been introduced in order to calculate the
appropriate drug administration, given the demographics
data of the patient. This is actually an open-loop control
system, thus subject to robustness issues. Thus, on another
side, many studies have also dealt with closed-loop control
systems that exploit the BIS level as a feedback variable to
automatically regulate the propofol infusion and improve
the control of DoH. Example of these control systems are
presented in (Ionescu et al., 2008; Nascu et al., 2012). In
any case, it is clear that a suitable model for the human
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number which ranges from 0, equivalent to EEG silence,
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the propofol infusion based on this index, on recommended
doses and on his/her experience. I order to improve the
efficacy of the treatment and the safety of the patient,
automatic and semi-automatic drug infusion systems have
been developed in the last decades. In particular, the
so-called target controlled infusion (TCI) (Ehrenfeld and
eds., 2014) has been introduced i order to calculate the
appropriate drug administration, given the demographics
data of the patient. This is actually a open-loop control
system, t us subject to robustness issues. Thus, on another
side, any studies have also dealt with closed-loop control
syste s that exploit the BIS level as a feedback variable to
auto atically regulate the propofol infusion and improve
the control of DoH. Example of these control systems are
presented in (Ionescu et al., 2008; Nascu et al., 2012). In
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body drug response is essential to develop an effective au-
tomatic infusion system that replicates and improves this
clinical procedure. In fact, in TCI-based systems the model
of the patient is implemented to calculate the infusion
profile, while in closed-loop control systems the model is
necessary for a correct design of the controller.
The patient model describes the relationship between the
propofol infusion rate and the drug effect measured by
the BIS. The effect of propofol is traditionally modelled
as a Wiener model, i.e., a model composed by a linear
part in series with a static nonlinearity. The linear part
consists of a pharmacokinetics (PK) model that describes
the infusion, distribution and elimination of the drugs in
the body and a pharmacodynamics (PD) part that rep-
resents the relationship between the plasma concentration
and the effect site concentration. The three compartmental
PK/PDmodel proposed by Schnider (Schnider et al., 1998,
1999) is typically adopted for propofol. The nonlinearity,
represented as a Hill function, expresses the relation be-
tween the effect site concentration and the clinical effect,
measured as the BIS level. The parameters of the nominal
model that have to be estimated are the compartment vol-
umes, the micro-constant rates for mass transfers between
compartments, the drug clearances in the human body
and the parameters of the Hill function. Such parameters
should be estimated on-line, during the clinical procedure.
However, the PK/PD model has a high number of param-
eters, which implies that a suitably exciting input, usually
not compatible with the standard administration proto-
cols, should be given to the patient in order to estimate
their values. In fact, the clinical practice usually consists
of the initial administration of a bolus of propofol in the
induction phase, followed by a constant infusion rate with
a low-variance profile. Moreover, clinical devices have in
general a limited sampling rate that reduces the number
of available data.
For this reason, a significant research effort has been pro-
vided in order to develop reduced models that describe
the propofol body response with a smaller number of
parameters. For example in (Sartori et al., 2005; Bibian
et al., 2006; Coppens et al., 2011) some parameters of
PK/PD model are fixed during the identification, in (Hahn
et al., 2012) a first-order model has been developed and
in (Lin et al., 2004) multivariable piecewise linear models
are used.
A reduced-order model that considers also the analgesic
drug has been presented in (da Silva et al., 2010) and vali-
dated in (da Silva et al., 2013). In this paper we propose a
modification of this reduced model to describe the relevant
case of the body response to propofol only. The goal is to
investigate the effectiveness of this reduced model and to
compare its performance with the one of Schnider’s model,
by using real surgical data. Indeed, by considering also
the presence of the analgesic drug, a comparison between
the two models has already been performed in (Mendonc¸a
et al., 2012). Therein, a prediction error method (PEM)
has been used to estimate the parameters of the reduced
model while a hybrid method presented in (Alonso et al.,
2008) has been used for the full model. However, as men-
tioned also in (Mendonc¸a et al., 2012), PEM requires a
proper tuning and presents convergence issues depend-
ing on the initial parameters choice. The hybrid method
does not have this problem, but it is developed only for
the identification of the nonlinear function parameters of
PK/PD model, considering parameters of the linear part
as known constants. For this reason, in this paper we use
genetic algorithms (GAs) (Mitchell, 1998) to estimate the
parameters of both models. GAs are capable to determine
a global optimum of an optimization problem in a stochas-
tic sense independently from the number of parameters. In
this context we also consider the PK/PD Schnider model
with and without fixed parameters in order to evaluate
their role in the overall identification procedure.
2. MODELS DESCRIPTION
2.1 PK/PD full model
The DoH induced by the propofol administration is usually
modelled by means of Wiener model, where a linear model
is in series with a static nonlinear function (Marsh et al.,
1991; Schnider et al., 1998, 1999; Vanluchene et al., 2004).
A mamillary three-compartmental model is adopted to
describe the (linear) PK model. This representation was
developed and validated on real patients by using blood
samples during anesthesia (Schnider et al., 1998, 1999).
The compartments are interconnected by a mass flux
exchange, so that the following system results:
q˙1(t) = −(k10 + k12 + k13)q1(t) + k21q2(t)+
+k31q3(t) + u(t)
q˙2(t) = k12q1(t)− k21q2(t)
q˙3(t) = k13q1(t)− k31q3(t)
(1)
where q(t) [mg] is the quantity of the drug over the time for
each compartment. In particular, q1(t) refers to primary
blood compartment, q2(t) refers to the peripheral fast
compartment that includes well perfused body tissues like
muscles, and q3(t) refers to slow dynamics compartment
that includes poor perfused body tissues like fat. The
input of the model is u(t) [mg/min] and represents the
infusion rate of the drug. The parameters kij for i = j
denote the drug transfer frequency from the ith to the
jth compartment. They depend on age, weight, height and
gender of the patient by means of the following parametric
relations:
V1 = t1, V2 = t2 − t7(age− 53), V3 = t3
Cl1 = t4 + t8(weight− 77)− t9(lbm− 59)
+t10(height− 177),
Cl2 = t5 − t11(age− 53), Cl3 = t6
k12 =
Cl2
V1
, k13 =
Cl3
V1
, k21 =
Cl2
V2
, k31 =
Cl3
V3
(2)
where Vi [L] and Cli [L/min] are, respectively, the volume
and the clearance of the ith compartment and lbm is the
lean body mass which can be obtained as (Hallynck et al.,
1981):
lbm = 1.1weight− 128weight
2
height2
for Male
lbm = 1.07weight− 148weight
2
height2
for Female
(3)
where weight is expressed in kilograms [kg] and height in
centimeters [cm]. The nominal values and the standard
errors of the parameters ti, i = 1, . . . , 11 used in the PK
model are shown in Table 1 (Schnider et al., 1998). The
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(hypnosis), the pain inhibition (analgesia), and the muscle
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body response to this drug and on the estimation of its
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in surgery or in the sedation of patients during invasive
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In order to measure the brain activity and therefore the
DoH, the bispectral index scale (BIS) is often employed.
This index is based on a bispectral analysis of the elec-
troencephalogram (EEG) and consists on a dimensionless
number which ranges from 0, equivalent to EEG silence,
to 100, equivalent to a fully awake state. In the standard
clinical practice the anesthesiologist manually regulates
the propofol infusion based on this index, on recommended
doses and on his/her experience. In order to improve the
efficacy of the treatment and the safety of the patient,
automatic and semi-automatic drug infusion systems have
been developed in the last decades. In particular, the
so-called target controlled infusion (TCI) (Ehrenfeld and
eds., 2014) has been introduced in order to calculate the
appropriate drug administration, given the demographics
data of the patient. This is actually an open-loop control
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patients show that the standard model fits the data better than the reduced model, but it is
overparameterized and its structure is much more complex to be used for the control design.
Conversely, the simplification of the identification procedure obtained with the reduced model,
which has only three parameters, is paid by only a slight decrement of the performance.
Keywords: Total intravenous anesthesia, Depth-of-Hypnosis, PK/PD model, Model reduction,
Genetic Algorithms.
1. INTRODUCTION
In surgery it is essential to provide an adequate level of
anesthesia to the patient. The aim of general anesthesia
is to temporarily induce the consciousness suppression
(hypnosis), the pain inhibition (analgesia), and the muscle
contraction inhibition (or relaxation) with specific drugs.
In this paper we focus on the use of propofol as anesthetic
in total intravenous anesthesia (TIVA) and in particular
on the mathematical model that describes the human
body response to this drug and on the estimation of its
parameters. Propofol is typically used in the induction
and maintenance of a desired depth of hypnosis (DoH)
in surgery or in the sedation of patients during invasive
medical exams such as endoscopy (Byrne et al., 2008).
In order to measure the brain activity and therefore the
DoH, the bispectral index scale (BIS) is often employed.
This index is based on a bispectral analysis of the elec-
troencephalogram (EEG) and consists on a dimensionless
number which ranges from 0, equivalent to EEG silence,
to 100, equivalent to a fully awake state. In the standard
clinical practice the anesthesiologist manually regulates
the propofol infusion based on this index, on recommended
doses and on his/her experience. In order to improve the
efficacy of the treatment and the safety of the patient,
automatic and semi-automatic drug infusion systems have
been developed in the last decades. In particular, the
so-called target controlled infusion (TCI) (Ehrenfeld and
eds., 2014) has been introduced in order to calculate the
appropriate drug administration, given the demographics
data of the patient. This is actually an open-loop control
system, thus subject to robustness issues. Thus, on another
side, many studies have also dealt with closed-loop control
systems that exploit the BIS level as a feedback variable to
automatically regulate the propofol infusion and improve
the control of DoH. Example of these control systems are
presented in (Ionescu et al., 2008; Nascu et al., 2012). In
any case, it is clear that a suitable model for the human
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para eters. ropofol is typically used in the induction
and aintenance of a desired depth of hypnosis ( o )
in surgery or in the sedation of patients during invasive
edical exa s such as endoscopy ( yrne et al., 2008).
In order to easure the brain activity and therefore the
o , the bispectral index scale ( IS) is often e ployed.
his index is based on a bispectral analysis of the elec-
troencephalogra ( ) and consists on a di ensionless
nu ber hich ranges fro 0, equivalent to silence,
to 100, equivalent to a fully a ake state. In the standard
clinical practice the anesthesiologist anually regulates
the propofol infusion based on this index, on reco ended
doses and on his/her experience. In order to i prove the
efficacy of the treat ent and the safety of the patient,
auto atic and se i-auto atic drug infusion syste s have
been developed in the last decades. In particular, the
so-called target controlled infusion ( I) ( hrenfeld and
eds., 2014) has been introduced in order to calculate the
appropriate drug ad inistration, given the de ographics
data of the patient. his is actually an open-loop control
syste , thus subject to robustness issues. hus, on another
side, any studies have also dealt ith closed-loop control
syste s that exploit the IS level as a feedback variable to
auto atically regulate the propofol infusion and i prove
the control of o . xa ple of these control syste s are
presented in (Ionescu et al., 2008; ascu et al., 2012). In
any case, it is clear that a suitable odel for the hu an
Proceedings of the 20th orld Congress
The International Federation of Auto atic Control
Toulouse, France, July 9-14, 2017
Copyright © 2017 IFAC 891
On the Identification of the Propofol
PK/PD Model Using BIS Measurements
Luca Merigo ∗ Fabrizio Padula ∗∗ Nicola Latronico ∗∗∗
Teresa Mendonc¸a ∗∗∗∗ Massimiliano Paltenghi † Paula Rocha ‡
Antonio Visioli §
∗Dipartimento di Ingegneria dell’Informazione, University of Brescia,
Brescia, Italy, (e-mail: l.merigo001@u ibs.it)
∗∗Department of Mathematics and Statistics, Curtin University,
Perth, Australia, (e- ail: fabrizio.padula@curtin.edu.au)
∗∗∗Department of Medical and Surgical Specialties, Radiological
Sciences and Public Health, University of Brescia, Brescia, Italy,
(e-mail: nicola.latronico@unibs.it)
∗∗∗∗ Faculdade de Cieˆncias, Universidade do Porto
Research Center for Systems and Technologies (SYSTEC),
Porto, Portugal (e-mail: tmendo@fc.up.pt)
†Department of Anesthesiology, Critical Care and Emergency, Spedali
Civili U iversity Hospital, Brescia, Italy, (e-mail:
maxpaltenghi@gmail.com)
‡ Faculdade de Engenharia, Universidade do Porto,
Research Center for Systems and Technologies (SYSTEC),
Porto, Portugal, (e-mail: mprocha@fe.up.pt)
§Dipartimento di Ingegneria Meccanica e Industriale, University of
Brescia, Brescia, Italy (e-mail: antonio.visioli@unibs.it)
Abstract: In this paper we analyse the use of different models to describe the effects of
propofol in the induction of hypnosis on a patient during surgery. In particular, we consider
the standard three-compartmental pharmacokinetics/pharmacodynamics Wiener model an a
suitable reduction of it. The estimation of the parameters is base on real bispectral index scale
s rgical data and it is performed by using genetic algorithms. The results obtained for different
patients show that the standar model fits the data better than the reduced model, but it is
overparameterized and its structure is much more complex to be used for the control design.
Conversely, the simplification of the identification procedure obtained with t e reduced model,
which has only three parameters, is paid by only a slight decreme t of the performance.
Keywords: Total intravenous anesthesia, Depth-of-Hypnosis, PK/PD model, Model reduction,
Genetic Algorithms.
1. INTRODUCTION
In surgery it is essential to provide an adequate level of
a esthesia to the patient. The aim of general anesthesia
is to temporarily induce the consciousness suppression
(hypnosis), the pain inhibition (analgesia), and the muscle
contraction inhibition (or relaxation) with specific drugs.
In this paper we focus on the use of propofol as anesthetic
i total intravenous anesthesia (TIVA) and in particular
on the mathematical model that describes the human
body response to this drug and on the estimation of its
parameters. Propofol is typically used in the induction
and aintenance of a desired depth of hypnosis (DoH)
in surgery or in the se ation of patients during invasive
medical exams suc as endoscopy (Byrne et al., 2008).
In order to easure the brain activity and therefore the
DoH, the bispectral index scale (BIS) is often employed.
This index is based on a bispectral analysis of the elec-
troencephalogram (EEG) and consists on a dimensionless
number which ranges from 0, equivalent to EEG silence,
to 100, equivalent to a fully awake state. In the standard
clinical practice the anesthesiologist manually regulates
the propofol infusion based on this index, on recommended
doses and on his/her experience. I order to improve the
efficacy of the treatment and the safety of the patient,
automatic and semi-automatic drug infusion systems have
been developed in the last decades. In particular, the
so-called target controlled infusion (TCI) (Ehrenfeld and
eds., 2014) has been introduced i order to calculate the
appropriate drug administration, given the demographics
data of the patient. This is actually a open-loop control
system, t us subject to robustness issues. Thus, on another
side, any studies have also dealt with closed-loop control
syste s that exploit the BIS level as a feedback variable to
auto atically regulate the propofol infusion and improve
the control of DoH. Example of these control systems are
presented in (Ionescu et al., 2008; Nascu et al., 2012). In
any case, it is clear that a suitable model for the huma
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body drug response is essential to develop an effective au-
tomatic infusion system that replicates and improves this
clinical procedure. In fact, in TCI-based systems the model
of the patient is implemented to calculate the infusion
profile, while in closed-loop control systems the model is
necessary for a correct design of the controller.
The patient model describes the relationship between the
propofol infusion rate and the drug effect measured by
the BIS. The effect of propofol is traditionally modelled
as a Wiener model, i.e., a model composed by a linear
part in series with a static nonlinearity. The linear part
consists of a pharmacokinetics (PK) model that describes
the infusion, distribution and elimination of the drugs in
the body and a pharmacodynamics (PD) part that rep-
resents the relationship between the plasma concentration
and the effect site concentration. The three compartmental
PK/PDmodel proposed by Schnider (Schnider et al., 1998,
1999) is typically adopted for propofol. The nonlinearity,
represented as a Hill function, expresses the relation be-
tween the effect site concentration and the clinical effect,
measured as the BIS level. The parameters of the nominal
model that have to be estimated are the compartment vol-
umes, the micro-constant rates for mass transfers between
compartments, the drug clearances in the human body
and the parameters of the Hill function. Such parameters
should be estimated on-line, during the clinical procedure.
However, the PK/PD model has a high number of param-
eters, which implies that a suitably exciting input, usually
not compatible with the standard administration proto-
cols, should be given to the patient in order to estimate
their values. In fact, the clinical practice usually consists
of the initial administration of a bolus of propofol in the
induction phase, followed by a constant infusion rate with
a low-variance profile. Moreover, clinical devices have in
general a limited sampling rate that reduces the number
of available data.
For this reason, a significant research effort has been pro-
vided in order to develop reduced models that describe
the propofol body response with a smaller number of
parameters. For example in (Sartori et al., 2005; Bibian
et al., 2006; Coppens et al., 2011) some parameters of
PK/PD model are fixed during the identification, in (Hahn
et al., 2012) a first-order model has been developed and
in (Lin et al., 2004) multivariable piecewise linear models
are used.
A reduced-order model that considers also the analgesic
drug has been presented in (da Silva et al., 2010) and vali-
dated in (da Silva et al., 2013). In this paper we propose a
modification of this reduced model to describe the relevant
case of the body response to propofol only. The goal is to
investigate the effectiveness of this reduced model and to
compare its performance with the one of Schnider’s model,
by using real surgical data. Indeed, by considering also
the presence of the analgesic drug, a comparison between
the two models has already been performed in (Mendonc¸a
et al., 2012). Therein, a prediction error method (PEM)
has been used to estimate the parameters of the reduced
model while a hybrid method presented in (Alonso et al.,
2008) has been used for the full model. However, as men-
tioned also in (Mendonc¸a et al., 2012), PEM requires a
proper tuning and presents convergence issues depend-
ing on the initial parameters choice. The hybrid method
does not have this problem, but it is developed only for
the identification of the nonlinear function parameters of
PK/PD model, considering parameters of the linear part
as known constants. For this reason, in this paper we use
genetic algorithms (GAs) (Mitchell, 1998) to estimate the
parameters of both models. GAs are capable to determine
a global optimum of an optimization problem in a stochas-
tic sense independently from the number of parameters. In
this context we also consider the PK/PD Schnider model
with and without fixed parameters in order to evaluate
their role in the overall identification procedure.
2. MODELS DESCRIPTION
2.1 PK/PD full model
The DoH induced by the propofol administration is usually
modelled by means of Wiener model, where a linear model
is in series with a static nonlinear function (Marsh et al.,
1991; Schnider et al., 1998, 1999; Vanluchene et al., 2004).
A mamillary three-compartmental model is adopted to
describe the (linear) PK model. This representation was
developed and validated on real patients by using blood
samples during anesthesia (Schnider et al., 1998, 1999).
The compartments are interconnected by a mass flux
exchange, so that the following system results:
q˙1(t) = −(k10 + k12 + k13)q1(t) + k21q2(t)+
+k31q3(t) + u(t)
q˙2(t) = k12q1(t)− k21q2(t)
q˙3(t) = k13q1(t)− k31q3(t)
(1)
where q(t) [mg] is the quantity of the drug over the time for
each compartment. In particular, q1(t) refers to primary
blood compartment, q2(t) refers to the peripheral fast
compartment that includes well perfused body tissues like
muscles, and q3(t) refers to slow dynamics compartment
that includes poor perfused body tissues like fat. The
input of the model is u(t) [mg/min] and represents the
infusion rate of the drug. The parameters kij for i = j
denote the drug transfer frequency from the ith to the
jth compartment. They depend on age, weight, height and
gender of the patient by means of the following parametric
relations:
V1 = t1, V2 = t2 − t7(age− 53), V3 = t3
Cl1 = t4 + t8(weight− 77)− t9(lbm− 59)
+t10(height− 177),
Cl2 = t5 − t11(age− 53), Cl3 = t6
k12 =
Cl2
V1
, k13 =
Cl3
V1
, k21 =
Cl2
V2
, k31 =
Cl3
V3
(2)
where Vi [L] and Cli [L/min] are, respectively, the volume
and the clearance of the ith compartment and lbm is the
lean body mass which can be obtained as (Hallynck et al.,
1981):
lbm = 1.1weight− 128weight
2
height2
for Male
lbm = 1.07weight− 148weight
2
height2
for Female
(3)
where weight is expressed in kilograms [kg] and height in
centimeters [cm]. The nominal values and the standard
errors of the parameters ti, i = 1, . . . , 11 used in the PK
model are shown in Table 1 (Schnider et al., 1998). The
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Table 1. Parameters for the PK model.
Parameter Value SE
t1 4.27 0.278
t2 18.9 2.330
t3 238 34.900
t4 1.89 0.059
t5 1.29 0.112
t6 0.836 0.044
t7 -0.391 0.070
t8 0.0456 0.009
t9 -0.0681 0.017
t10 0.0264 0.009
t11 -0.024 0.005
output of the model is the plasmatic concentration of the
drug, calculated as Cp(t) = q1(t)/V1 and it is also the
input of the PD part of the model. In the pharmacody-
namics model, a fictitious compartment called effect-site
compartment is added to represent the lag between the
plasma concentration and the corresponding drug effect.
The drug concentration in the effect-site compartment is
denoted as Ce. The relation between the primary and
the effect-site compartment is represented by a first-order
delay-free function:
C˙e(t) = k1eCp(t)− ke0Ce(t) (4)
According to Schnider et al. (1999), the propofol transfer
frequency k1e can be considered constant and equal to the
frequency of drug removal from the effect-site compart-
ment ke0:
k1e = ke0 = 0.456 [min
−1] (5)
Finally, a static nonlinear function, known as Hill function,
correlates the effect-site drug concentration and clinical
effect, represented by the BIS (Struys et al., 2003; Van-
luchene et al., 2004; Ionescu et al., 2008). This sigmoid
function can be written as
BIS(t) = E0 − Emax
(
Ce(t)
γ
Ce(t)γ + C
γ
e50
)
, (6)
where E0 is the baseline value representing the BIS level
of the patient in the initial state before the infusion,
E0−Emax is the maximum reachable effect achieved by
the infusion, γ denotes the steepness of the curve that
represents the receptiveness of the patient to the drug and
Ce50 is the necessary concentration of the drug to reach
the half maximal effect. Eventually the parameters to be
estimated for the full PK/PD model are:
θ = (t1 t2 t3 t4 t5 t6 t7 t8 t9 t10 t11
E0 Emax Ce50 γ)
(7)
In many works the nominal values of the ti parameters are
assumed in order to reduce the complexity of the identifi-
cation procedure, but this issue will be fully investigated
in the following sections.
2.2 Minimally parameterized model
A new Wiener model has been proposed in (da Silva et al.,
2010) to describe the response of the human body to both
propofol and remifentanil. The latter is a typical analgesic
drug given with propofol during general anesthesia. In this
paper that model is suitably adapted in order to represent
only the propofol response. The model reduction is based
on the model structure presented in (da Silva et al., 2012),
where a new single-input single-output (SISO) Wiener
model is developed for the human response to atracurium,
a neuromuscular blockade drug. In (da Silva et al., 2010)
the linear dynamics of the propofol model is described by
a third-order continuous-time model. We maintain that
structure also to describe the response of propofol only,
thus obtaining:
Xˆprope (s, α) =
k1k2k3α
3
(s+ k1α)(s+ k2α)(s+ k3α)
Rprop(s) (8)
where Xˆprope (s, α) is the Laplace transform of the output
of the linear part of the model, that is, the effect-site
concentration, and Rprop(s) is the Laplace transform of
the input, that is, the propofol infusion rate in [mg/min].
The transfer function (8) has a single parameter α to be
estimated, which depends on the patient. The parameters
ki, i = 1, ..., 3 have been determined by using a batch
identification procedure over a large database of patients
(da Silva et al., 2010). These parameters are fixed at
the values k1 = 10, k2 = 9, k3 = 1. As for the full
Schnider model, a nonlinear function describes the relation
between the effect-site concentration and the clinical effect
of propofol, measured by the BIS index. By applying
the approximation proposed in (da Silva et al., 2010), a
reduction of the Hill equation (6) is performed by fixing
the baseline value E0 to the maximum reachable effect
Emax = y0, where y0 = 97.7 is the commercial BIS monitor
saturation value. Nevertheless, on the contrary of what has
been done in (da Silva et al., 2010), where the value of Ce50
for both propofol and remifentanil is fixed to the average
patients value, here the value of Ce50 is a parameter to be
estimated, yielding:
BIS(t) =
y0
1 +
(
Ce(t)
Ce50
)γ (9)
The rationale behind this choice is to obtain a better
estimation of the gain of the system.
The parameters to be estimated for this new reduced
model are therefore:
θ = (α γ Ce50) (10)
3. CLINICAL DATA
The data used in this paper for the model identification
purpose have been collected during plastic surgeries in
the Department of Anesthesia, Critical Care Medicine and
Emergency of the Brescia University Hospital (Italy). The
patients were subject to total intravenous anesthesia using,
along the whole surgery, both propofol and remifentanil.
Induction and maintenance of anesthesia was based on
standard clinical practice, and was not modified for the
purpose of this study. In particular, the drug administra-
tion protocol has been established in such a way that,
in the initial induction phase, only propofol was used
and no external stimuli were provided to the patients.
Remifentanil was added only after obtaining a steady-
state BIS level, that is, about after 5 [min] from the bolus
injection. The induction phase can be therefore used for
the parameter identification of the model that describes
the human body response to propofol.
The induction phase consists of a drug bolus followed by
a constant infusion rate in order to achieve the desired
BIS value in a range between 40 and 60. The time in-
terval for the bolus administration and the amount of
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Table 2. Patients data.
Patient Gender Weight [Kg] Age Height [cm]
1 F 90 83 160
2 F 63 68 160
3 F 81 68 158
4 F 60 51 158
5 M 120 27 160
6 F 60 13 170
7 M 70 68 168
8 F 54 56 160
Table 3. Results obtained by estimating only
the Hill function parameters of the full model.
Patient Emax Ce50 γ Var.
1 144.2614 6.1211 2.1479 171.41
2 70.4017 3.8238 15.8079 38.1629
3 105.4477 4.0905 1.9497 233.9927
4 158.5657 8.9067 1.2018 255.9543
5 147.0424 5.8686 2.8697 92.6355
6 156.0934 6.5781 1.5291 151.8139
7 126.4284 10.3198 1.0286 225.2469
8 52.4876 4.0654 43.4104 44.7005
administered drug were decided by the anesthesiologist
based on recommended doses and on his/her own clinical
experience. The anesthesiologist manually controlled the
infusion rate by using an Orchestra module DPS pump and
checked the BIS level of the patient on a Draeger Infinity
Delta monitor. Through this instrumentation, by means of
appropriate protocols, it is possible to collect the propofol
infusion rate and the BIS value with a standard PC with a
sampling period of one second. The data of eight patients
(whose characteristics are shown in Table 2) have been
used for the purpose of this paper.
4. IDENTIFICATION OF THE FULL MODEL
4.1 Estimation of the Hill function parameters only
The first approach that has been considered for the iden-
tification of the full PK/PD model is based on the esti-
mation of the parameters of the nonlinear part only, that
is, the Hill function parameters, as suggested in (Alonso
et al., 2008). In particular, the parameters to estimate are
Emax, Ce50 and γ, while the average (nominal) values of
the parameters ti, i = 1, . . . , 11, reported in Table 1 are
considered for the linear part. As in (Alonso et al., 2008;
da Silva et al., 2010), the parameter E0 of the nonlinear
function is fixed at the saturation value y0 of the BIS
monitor.
As mentioned in the introduction, GAs have been used
to find the values of the parameters that minimize the
variance between the measured BIS and the model output
obtained by using the employed propofol infusion profile
as input. It is worth noting that, with respect to other
optimization approaches, GAs do not require a starting
point: it is only necessary to define the search space, which
can be easily provided by considering the physical meaning
of the parameters.
The results obtained for the considered set of patients are
shown in Table 3. As an illustrative example, the com-
parison between the measured BIS signal and the model
output for the patient 1 is presented in Figure 1 with
blue line. Similar results are found for the other patients
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Fig. 1. Results obtained for patient 1. Top plot: measured
BIS signal (black line) and model outputs. Bottom
plot: propofol infusion rate.
but they are not shown for the sake of brevity. It can be
seen that, although the general trend is captured by the
model, the result is not very satisfactory. For this reason
it is necessary to investigate the improvement that can be
achieved by including the parameters of the linear part in
the overall estimation procedure.
4.2 Estimation of all the parameters
The second approach consists in estimating, again by using
GAs, all the parameters appearing in (7). Of course, the
procedure is much complex than the one performed in the
previous section because the parameters to estimate are
14 instead of 3. However, the fact that the parameters
of the linear part are no longer fixed, allows to address
the inter-patient variability and therefore an improvement
of the model. Note that, again, the value of E0 is set to
97.7 as in the previous approach. The search space for
the ti parameters can be easily determined by considering
their nominal values and their standard errors reported in
Table 1.
The results obtained in this case are shown in Table 4.
It appears that the obtained variances (to be minimized
by the GA) are significantly smaller compared to the ones
obtained in the previous case. The improvement of the
accuracy of the model is confirmed by considering again
patient 1 as illustrative example. The comparison between
the measured BIS and the model output is plotted in
Figure 1 with red line.
Despite the performance improvement achieved by esti-
mating all the parameters (note also that GAs are able
to handle an incremented number of parameters at the
expense of an increase of computational complexity), it
has to be noted that this approach presents a significant
problem. In fact, the genetic algorithms can find different
solutions with almost the same cost function. This means
that there are local minima in the cost function with
almost the same degree of optimality, that is, the model is
actually overparameterized. An example is shown in Ta-
ble 5, where two different results related to the application
of the genetic algorithm to patient 1 are reported. It can
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Table 2. Patients data.
Patient Gender Weight [Kg] Age Height [cm]
1 F 90 83 160
2 F 63 68 160
3 F 81 68 158
4 F 60 51 158
5 M 120 27 160
6 F 60 13 170
7 M 70 68 168
8 F 54 56 160
Table 3. Results obtained by estimating only
the Hill function parameters of the full model.
Patient Emax Ce50 γ Var.
1 144.2614 6.1211 2.1479 171.41
2 70.4017 3.8238 15.8079 38.1629
3 105.4477 4.0905 1.9497 233.9927
4 158.5657 8.9067 1.2018 255.9543
5 147.0424 5.8686 2.8697 92.6355
6 156.0934 6.5781 1.5291 151.8139
7 126.4284 10.3198 1.0286 225.2469
8 52.4876 4.0654 43.4104 44.7005
administered drug were decided by the anesthesiologist
based on recommended doses and on his/her own clinical
experience. The anesthesiologist manually controlled the
infusion rate by using an Orchestra module DPS pump and
checked the BIS level of the patient on a Draeger Infinity
Delta monitor. Through this instrumentation, by means of
appropriate protocols, it is possible to collect the propofol
infusion rate and the BIS value with a standard PC with a
sampling period of one second. The data of eight patients
(whose characteristics are shown in Table 2) have been
used for the purpose of this paper.
4. IDENTIFICATION OF THE FULL MODEL
4.1 Estimation of the Hill function parameters only
The first approach that has been considered for the iden-
tification of the full PK/PD model is based on the esti-
mation of the parameters of the nonlinear part only, that
is, the Hill function parameters, as suggested in (Alonso
et al., 2008). In particular, the parameters to estimate are
Emax, Ce50 and γ, while the average (nominal) values of
the parameters ti, i = 1, . . . , 11, reported in Table 1 are
considered for the linear part. As in (Alonso et al., 2008;
da Silva et al., 2010), the parameter E0 of the nonlinear
function is fixed at the saturation value y0 of the BIS
monitor.
As mentioned in the introduction, GAs have been used
to find the values of the parameters that minimize the
variance between the measured BIS and the model output
obtained by using the employed propofol infusion profile
as input. It is worth noting that, with respect to other
optimization approaches, GAs do not require a starting
point: it is only necessary to define the search space, which
can be easily provided by considering the physical meaning
of the parameters.
The results obtained for the considered set of patients are
shown in Table 3. As an illustrative example, the com-
parison between the measured BIS signal and the model
output for the patient 1 is presented in Figure 1 with
blue line. Similar results are found for the other patients
0 1 2 3 4 5 6
Time [min]
20
40
60
80
100
BI
S 
Le
ve
l
0 1 2 3 4 5 6
Time [min]
0
10
20
30
40
50
60
70
In
fu
sio
n 
ra
te
 [m
g/m
in]
Fig. 1. Results obtained for patient 1. Top plot: measured
BIS signal (black line) and model outputs. Bottom
plot: propofol infusion rate.
but they are not shown for the sake of brevity. It can be
seen that, although the general trend is captured by the
model, the result is not very satisfactory. For this reason
it is necessary to investigate the improvement that can be
achieved by including the parameters of the linear part in
the overall estimation procedure.
4.2 Estimation of all the parameters
The second approach consists in estimating, again by using
GAs, all the parameters appearing in (7). Of course, the
procedure is much complex than the one performed in the
previous section because the parameters to estimate are
14 instead of 3. However, the fact that the parameters
of the linear part are no longer fixed, allows to address
the inter-patient variability and therefore an improvement
of the model. Note that, again, the value of E0 is set to
97.7 as in the previous approach. The search space for
the ti parameters can be easily determined by considering
their nominal values and their standard errors reported in
Table 1.
The results obtained in this case are shown in Table 4.
It appears that the obtained variances (to be minimized
by the GA) are significantly smaller compared to the ones
obtained in the previous case. The improvement of the
accuracy of the model is confirmed by considering again
patient 1 as illustrative example. The comparison between
the measured BIS and the model output is plotted in
Figure 1 with red line.
Despite the performance improvement achieved by esti-
mating all the parameters (note also that GAs are able
to handle an incremented number of parameters at the
expense of an increase of computational complexity), it
has to be noted that this approach presents a significant
problem. In fact, the genetic algorithms can find different
solutions with almost the same cost function. This means
that there are local minima in the cost function with
almost the same degree of optimality, that is, the model is
actually overparameterized. An example is shown in Ta-
ble 5, where two different results related to the application
of the genetic algorithm to patient 1 are reported. It can
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Table 4. Results obtained by estimating all the parameters of the full model.
Patient Emax Ce50 γ t1 t2 t3 t4 t5 t6 t7 t8 t9 t10 t11 Var.
1 63.3403 4.9209 32.2025 5.4495 11.8436 144.2989 1.7821 1.1130 0.8504 -0.3606 0.0374 0.0063 0.0649 -0.0140 16.9236
2 77.9273 5.1806 3.6700 4.7059 27.4241 387.7539 2.1026 0.9036 0.7245 -0.2721 0.0762 0.0026 0.0490 -0.0361 5.9077
3 69.4207 5.2024 4.0516 5.6405 10.2382 256.0284 1.6528 1.3817 0.6198 -0.6428 0.0151 0.0067 0.0615 -0.0420 16.7245
4 66.1865 5.3831 6.9119 5.4904 7.3125 247.8711 1.6394 1.8371 0.6926 -0.0865 0.0839 -0.0324 0.0039 -0.0262 39.5793
5 67.3865 4.9293 14.4104 3.8203 11.0654 396.9805 1.8452 1.6023 0.9549 -0.4712 0.0239 -0.1126 0.0504 -0.0486 16.4827
6 77.2297 4.8383 6.7710 4.1405 10.6118 222.2261 1.7141 1.8486 0.7252 -0.0584 0.0692 -0.0817 0.0619 -0.0355 11.2708
7 64.0798 8.5981 6.3765 5.6203 9.0954 301.8072 1.6107 1.1771 0.8277 -0.5649 0.0753 -0.0001 0.0370 -0.0422 38.6729
8 69.9069 5.9314 2.0097 4.0717 7.4595 105.8133 1.7394 1.7908 0.7772 -0.5431 0.0696 -0.0054 0.0705 -0.0107 18.7593
be noted that, despite the important differences in the
parameter, the obtained variances are very similar.
5. IDENTIFICATION OF THE REDUCED MODEL
As mentioned in Section 2.2, a reduced model has been
devised by removing the effects of the remifentanil from
the model presented in (da Silva et al., 2010). In this
case the three parameters to estimate are α, γ and Ce50 .
It is worth noting that the number of parameters is
the same as in case of the full model where only the
nonlinear part is considered, but here the parameter α
allows the modification of the linear part. This is an
important difference because this parameter can modify
the dynamic response significantly. By using again a GA-
based approach, the results shown in Table 6 are obtained
(the corresponding results for patient 1 are plotted in
Figure 1 with green line.
It can be seen that in general the performance is only
slightly worse than the one obtained by using the full
model and the reduced model can be considered to be in
any case effective in representing the propofol effect in the
induction phase.
6. DISCUSSION
The variances obtained for the different patients with the
considered approaches are summarized in Figure 2. As it
has been already pointed out, it appears that the use of
the full model with the estimation of all the parameters
provides the best performance in matching the real BIS
signal. However, it also presents severe problems because
of the overparameterization of the model. Furthermore,
the number of parameters to estimate is very high and for
this reason the model is unsuitable to be used in an online
estimation context. It is worth noting that in this paper
GAs have been used in order to provide a fair comparison
between the different techniques, as they provide a global
optimum of the optimization problem, but the use of this
tool is very computationally demanding.
The solution to fix the linear part of the model based
just on the demographics of the patient and to consider
only the nonlinear part in the estimation procedure greatly
simplifies the estimation procedure, but it does not provide
satisfactory results. In fact, the main disadvantage in this
case is that the time constants of the linear part are fixed
and this prevents the model to address the intra-patient
variability and therefore to capture the whole dynamics of
the system. On the contrary, the minimally parameterized
reduced model (8) allows the selection of the time con-
stants through the parameter α (without affecting the gain
that is normalized to one) and eventually it guarantees a
very good compromise between the obtained accuracy and
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Fig. 2. Comparison between the variances obtained with
the considered approaches for the different patients.
Black line: full model with the estimation of the
Hill function parameters only. Red line: full model
with the estimation of all the parameters. Green line:
reduced model.
the simplicity of implementation, although the physical
meaning of the parameters is partially lost.
7. CONCLUSIONS
In this paper the identification of the human body response
to propofol has been analyzed. In particular, three different
approaches have been compared by using genetic algo-
rithms. The first two methods consider the full Schnider
model. In the first case the linear part is fixed for a
given patient and only the Hill function parameters are
estimated, while in the second case all the parameters are
determined in the identification procedure. In the third
approach a reduced model has been implemented. The
results obtained by considering a set of patients show that
the reduced model is capable to capture quite well the dy-
namics of the system and does not present the drawbacks
of the full model, in particular, the overparameterization
of the model.
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Table 5. Results of two applications of the GA for the estimation of all the parameters of the
full model of patient 1.
Patient Emax Ce50 γ t1 t2 t3 t4 t5 t6 t7 t8 t9 t10 t11 Var.
1A 63.3403 4.9209 32.2025 5.4495 11.8436 144.2989 1.7821 1.1130 0.8504 -0.3606 0.0374 0.0063 0.0649 -0.0140 16.9236
1B 63.3580 4.6511 33.3519 5.5149 24.7021 287.8014 1.6158 1.3723 0.8618 -0.3138 0.0182 -0.0216 0.0701 -0.0029 16.9150
Table 6. Results obtained by estimating the
reduced model.
Patient α γ Ce50 Var.
1 0.1994 2.7775 11.2619 37.3219
2 0.1670 1.8590 6.4880 11.3181
3 0.1596 2.0515 8.2996 20.6812
4 0.1791 2.4993 11.7378 49.1722
5 0.3020 4.1053 22.6953 37.4264
6 0.2305 2.7957 14.1694 25.6980
7 0.1534 3.0209 14.1305 39.7877
8 0.1171 0.8362 4.4035 23.6276
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